TIDMOCI
RNS Number : 8505C
Oakley Capital Investments Limited
22 October 2020
22 October 2020
Oakley Capital Investments Limited
Oakley Capital acquires WindStar Medical, a leading consumer
healthcare company
-- Transaction: Oakley Fund IV agrees to acquire WindStar Medical
-- Investment: OCI's indirect contribution will be up to c.GBP43 million
Oakley Capital Investments Limited(1) (the "Company" or "OCI")
is pleased to announce that Oakley Capital IV(2) ("Fund IV") has
agreed to acquire WindStar Medical GmbH ("WindStar Medical") from
ProSiebenSat.1 majority-owned NuCom Group.
WindStar Medical is Germany's leading over-the-counter ("OTC")
consumer healthcare company. The platform, which is expected to
generate over EUR120 million in revenues this year, d esigns,
develops and commercialises branded consumer health and private
label products, with a track record of establishing best-in-class
medical formulations and brands.
The Consumer Brands segment of WindStar Medical offers a wide
range of premium high-growth branded products in Germany, including
SOS ( wound care / disinfectants), Zirkulin (gastro-intestinal
care), GreenDoc (mental wellbeing) and EyeMedica (eye health).
WindStar Medical is also a provider of Private Label products to
the leading German drug stores and supermarkets, whilst also
developing an international distribution footprint through existing
and new partners.
WindStar Medical benefits from the long-term structural growth
of Germany's consumer health market. This growth is being driven
both by demographic trends, such as an ageing population, and a
shift in consumer preferences driven by factors such as increased
awareness of physical and mental wellbeing and willingness to
prevent illness. Through its investment, Oakley will support the
company's management team as they continue to drive revenue growth,
product innovation, digitalisation, as well as identifying
opportunities to scale the business through accretive
acquisitions.
The investment in WindStar Medical builds on Oakley's successful
track record of investing in leading consumer platforms in the DACH
region, including Verivox, Parship Elite and more recently Wishcard
Technologies and 7NXT / Gymondo. The business displays the typical
Oakley deal characteristics, as it has an asset-light business
model, industry-leading operational capabilities, and an attractive
growth profile.
OCI's indirect contribution through its interest in Fund IV will
be up to c. GBP 43 million, dependent on the capital structure at
completion, and the transaction is expected to be completed by the
end of the year.
Peter Dubens, Managing Partner of Oakley Capital, commented:
"WindStar Medical is a unique OTC platform in a highly
attractive space that Oakley is excited to be investing in, having
closely followed both the development of the business and
management over recent years. We look forward to working together
with the team and utilising our broad expertise in digitalisation,
go-to-market and M&A to help WindStar Medical accelerate its
growth trajectory in Germany and international markets."
- ends -
For further information please contact:
Oakley Capital Limited
+44 20 7766 6900
Steven Tredget, Investor Relations
Greenbrook Communications Limited
+44 20 7952 2000
Alex Jones / Gina Bell / James Williams
Liberum Capital Limited (Financial Adviser & Broker)
+44 20 3100 2000
Gillian Martin / Owen Matthews
Notes:
This announcement contains inside information for the purposes
of the Market Abuse Regulation (EU) No. 596/2014
LEI Number: 213800KW6MZUK12CQ815
(1) About Oakley Capital Investments Limited ("OCI")
OCI is a Specialist Fund Segment ("SFS") traded investment
vehicle that aims to provide shareholders with consistent long-term
capital growth in excess of the FTSE All-Share Index by providing
liquid access to private equity returns through investment in the
Oakley Funds(2) .
A video introduction to OCI is available at
https://oakleycapitalinvestments.com/videos/
(2) The Oakley Funds
Oakley Capital Private Equity L.P. and its successor funds,
Oakley Capital Private Equity II, Oakley Capital Private Equity
III, Oakley Capital IV and Oakley Capital Origin Fund are unlisted
lower-mid to mid-market private equity funds that aim to provide
investors with significant long-term capital appreciation. The
investment strategy of the Funds is to focus on buy-out
opportunities in industries with the potential for growth,
consolidation and performance improvement.
Oakley Capital, the Investment Adviser
Founded in 2002, Oakley Capital Limited has demonstrated the
repeated ability to source attractive growth assets at attractive
prices. To do this it relies on its sector and regional expertise,
its ability to tackle transaction complexity and its deal
generating entrepreneur network.
Important information
Specialist Fund Segment securities are not admitted to the
Official List of the Financial Conduct Authority. Therefore, the
Company has not been required to satisfy the eligibility criteria
for admission to listing on the Official List and is not required
to comply with the Financial Conduct Authority's Listing Rules.
The Specialist Fund Segment is intended for institutional,
professional, professionally advised and knowledgeable investors
who understand, or who have been advised of, the potential risk
from investing in companies admitted to the Specialist Fund
Segment.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACQMBBBTMTATTBM
(END) Dow Jones Newswires
October 22, 2020 02:00 ET (06:00 GMT)
Oakley Capital Investments (LSE:OCI)
Historical Stock Chart
From Apr 2024 to May 2024
Oakley Capital Investments (LSE:OCI)
Historical Stock Chart
From May 2023 to May 2024